INTRODUCTION
Socioeconomically vulnerable patients experience high rates of pain, barriers to care, 1 and risks from conventional pain treatments. 2 Multimodal, non-pharmacologic approaches are recommended as first-line treatments for chronic pain, 3 but are often unavailable in resourcelimited settings. We evaluated the impact of a multimodal chronic pain management program among patients at a safety-net clinic.
METHODS

Setting and Intervention. We developed the Integrative Pain Management Program (IPMP) at Tom Waddell Urban
Health Clinic (TWUHC), a public health, primary care clinic in San Francisco. TWUHC provides healthcare for diverse, marginalized patients with high rates of homelessness, chronic disease, chronic pain, and substance use. IPMP consists of a core 12-week program centered around a weekly Bhome group^that provides education on the biopsychosocial model of pain and multimodal treatments, physical movement, mindfulness training, and peer support. Patients also receive acupuncture, massage, and health coaching. After the core program, IPMP patients have ongoing access to weekly groups, offering peer support, education, mindfulness, movement, and acupuncture.
Design, Participants, and Measures. We evaluated IPMP using a quasi-experimental design comparing IPMP participants vs. eligible, interested patients who had not yet enrolled in IPMP. Participants were referred by a primary care provider. Eligible patients reported pain > 3 months and were prescribed opioids. We excluded patients who were non-English speaking, pregnant, or unable to participate in groups. IPMP participants completed validated surveys of pain-related outcomes 4, 5 at baseline, 3 months, and 6 months. Eligible patients who were interested in IPMP but could not immediately enroll due to scheduling or other barriers were invited to complete surveys at baseline and 3 months, forming a non-randomized comparison group.
Analysis. We used linear mixed models (LMMs) to analyze changes in patient-reported outcomes from baseline to 3-and 6-month follow-up. We conducted two sets of analyses using LMMs: changes in outcomes for IPMP participants vs. comparison group; and changes in outcomes of IPMP participants who attended < 8 home groups vs. ≥ 8 home groups.
RESULTS
Primary care providers referred 146 patients to IPMP; 73 were eligible and interested; 61 consented to research (IPMP participants n = 41, comparison group n = 20). Participants were low-income and racially/ethnically diverse; 13% were unstably housed; 96% reported chronic pain for > 1 year. Relative to the comparison group, IPMP participants had less optimal mental health and were prescribed lower opioid doses (Table 1) .
IPMP participants had statistically significant improvements in pain interference, pain intensity, social satisfaction, global mental health, and pain self-efficacy at 3 and 6 months ( Table 2) . No statistically significant changes were observed in other measures. We did not observe significant changes in the comparison group for any patient-reported outcomes, except for physical functioning at 3 months. IPMP participants who attended ≥ 8 home groups (n = 26) reported greater improvements in most outcomes (Table 2 ), though differences were not significant when compared to changes in those who attended < 8 home groups (n = 20).
DISCUSSION
Among a sample of diverse at-risk participants, we observed statistically significant and clinically relevant improvements in pain interference, social satisfaction, and global mental health that were sustained at 6 months. Changes in pain intensity were statistically significant and sustained at 6 months, but not at a magnitude considered clinically relevant. A high proportion of patients in the program have unstable housing and histories of trauma, thought to create barriers to engagement with multimodal pain management. Our findings suggest that implementation of a multimodal program may improve patients' quality of life, even for patients known to be medically, psychosocially, and behaviorally complex.
We used a non-randomized design to ensure that patients could enroll in IPMP as soon as possible. A lack of randomization, self-selection, and baseline differences between IPMP participants and the comparison group may have biased our findings. Compared with non-participants, IPMP participants had lower overall opioid doses and may have been motivated to participate in IPMP due to unresolved pain, recent opioid tapering, or interest in nonpharmacologic options. Generalizability may be limited because IPMP was supported by institutional funding and in-kind staff support not available in all settings. Nonetheless, our study contributes to the sparse literature on integrative pain approaches in safety net settings. 6 We provide practice-based data suggesting that increasing access to non-pharmacologic approaches in primary care safety-net settings may be a strategy to improve pain management for vulnerable patients with chronic pain. 
